Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 227 of 239
83307B101
Shares:457
Value:$644
% of Portfolio:0.0% ($644/$44.8B)
Commercial Vehicle Group, Inc.
Shares:552
Value:$635
% of Portfolio:0.0% ($635/$44.8B)
Biomea Fusion, Inc.
Shares:297
Value:$633
% of Portfolio:0.0% ($633/$44.8B)
HireQuest, Inc.
Shares:53
Value:$631
% of Portfolio:0.0% ($631/$44.8B)
X4 Pharmaceuticals, Inc
Shares:2.6K
Value:$622
% of Portfolio:0.0% ($622/$44.8B)
922042676
Shares:15
Value:$607
% of Portfolio:0.0% ($607/$44.8B)
ULTRALIFE CORP
Shares:112
Value:$602
% of Portfolio:0.0% ($602/$44.8B)
Corbus Pharmaceuticals Holdings, Inc.
Shares:113
Value:$600
% of Portfolio:0.0% ($600/$44.8B)
Emerald Holding, Inc.
Shares:150
Value:$590
% of Portfolio:0.0% ($590/$44.8B)
TPI COMPOSITES, INC
Shares:719
Value:$580
% of Portfolio:0.0% ($580/$44.8B)
Acumen Pharmaceuticals, Inc.
Shares:526
Value:$579
% of Portfolio:0.0% ($579/$44.8B)
Traeger, Inc.
Shares:343
Value:$576
% of Portfolio:0.0% ($576/$44.8B)
Greenwich LifeSciences, Inc.
Shares:60
Value:$572
% of Portfolio:0.0% ($572/$44.8B)
Liberty Media Corp
Shares:7
Value:$570
% of Portfolio:0.0% ($570/$44.8B)
Artiva Biotherapeutics, Inc.
Shares:188
Value:$564
% of Portfolio:0.0% ($564/$44.8B)
LanzaTech Global, Inc.
Shares:2.3K
Value:$562
% of Portfolio:0.0% ($562/$44.8B)
INOVIO PHARMACEUTICALS, INC.
Shares:344
Value:$561
% of Portfolio:0.0% ($561/$44.8B)
InnovAge Holding Corp.
Shares:188
Value:$560
% of Portfolio:0.0% ($560/$44.8B)
Purple Innovation, Inc.
Shares:726
Value:$551
% of Portfolio:0.0% ($551/$44.8B)
IGM Biosciences, Inc.
Shares:474
Value:$546
% of Portfolio:0.0% ($546/$44.8B)